CClinicalTrials.gg
Sign In
Active, not recruitingNCT06257849Updated Oct 1, 2025

Validity and Reliability of a Danish Version of the Banff Patella Instability Instrument (BPII 2.0-DK)

An observational study in Patella Dysplasia, sponsored by Aarhus University Hospital. Active, not recruiting at 2 sites in Denmark. Open to participants aged 14 Years to 40 Years. Per ClinicalTrials.gov, last updated 2025-10-01.

Sponsored by Aarhus University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
65
Ages
14 Years to 40 Years
Sex
All
01

Study summary

The Banff Patella Instability Instrument (BPII 2.0) is a disease-specific quality of life questionnaire designed to assess adults with patellar dislocations.

As the BPII 2.0 already is cross-cultural translate and adapted to Danish the examination of the the psychometric properties of the Danish version is still needed

The aim om this study is to determine validity and reliability of the Danish version BPII 2.0-DK in a Danish populations of patients with patellar dislocation.

02

Conditions studied

  • Patella Dysplasia

Keywords

  • BPII 2.0
  • Patella instability
  • Knee
  • Questionnaire
03

In context

Lead sponsor

Aarhus University Hospital is the lead sponsor of 289 studies on the registry; 79 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 40 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients with Patella instability

Inclusion criteria

  • Danish Speaking
  • Patella instability problems

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
65 participants (estimated)
Patient registry
No

Interventions

  • OtherBPII 2.0

    Banff Patella Instability Instrument 2.0 is a questionnaire developed for measuring outcome in patients with patella instability

    Also known as: Banff Patella Instability Instrument 2.0

06

What researchers measure

Primary outcomes

  1. Banff patella instability instrument (BPII 2.0)

    Questionnaire. (0-100 (0 = Worst, 100 = Best))

    Time frame: Baseline, after 6-8 days

  2. Anterior knee pain scale (Kujala)

    Questionnaire. (0-100 (0 = Worst, 100 = Best))

    Time frame: Baseline

  3. Victorian Institute of Sports Assessment - Patella questionnaire (VISA-P)

    Questionnaire. (0-100 (0 = Worst, 100 = Best))

    Time frame: Baseline

  4. International knee documentation committee (IKDC)

    Questionnaire. (0-100 (0 = Worst, 100 = Best))

    Time frame: Baseline

07

Study locations

2 sites
  • Aarhus University Hospital
    Aarhus, 8200, Denmark
  • Division of Sports Trauma, Palle Juul-Jensens Boulevard 99
    Aarhus N, 8200, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06257849
Lead sponsor
Aarhus University Hospital
Responsible party
Martin Lind (Professor, PhD, MD, Aarhus University Hospital) — Principal investigator
First posted
Feb 14, 2024
Start date
Mar 1, 2024
Primary completion
Oct 1, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Oct 1, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Aarhus University Hospital

Start the discussion